Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Feb 2025 for Xeris Biopharma Holdings, Inc., €53k.
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kenneth Erland Johnson: trading record in brief
Filings by Kenneth Erland Johnson span 2 companies, the busiest being Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals Inc. Over a trading history stretching from 25 June 2018 to 31 January 2025, the count stands at 26 filings.
On the market, this insider has only ever bought: 2 purchases, €18k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 21 share grants.
The latest filing, published on 3 February 2025, reports a share grant of €88k in Xeris Biopharma Holdings, Inc. The last purchase on record was published on 18 February 2020, which is 2,441 days ago. The median gap between a trade and its publication by SEC (Form 4) is 6 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kenneth Erland Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
15,476 shares@ US$3.5647.8% of flowCommon StockSEC:0001867096-25-000023:0
12,401 shares@ US$3.6139.4% of flowCommon StockSEC:0001867096-25-000013:0
7,497 shares@ US$2.1112.8% of flowCommon StockSEC:0001867096-24-000169:0
175,000 shares0Common StockSEC:0001867096-24-000016:0
100,000 shares0Common StockSEC:0001867096-23-000019:0
75,000 shares0Common StockSEC:0001867096-22-000010:0
11,250 sharesCommon StockSEC:0000899243-21-039319:0
11,250 sharesCommon StockSEC:0000899243-21-039246:0
8 of 8 declarations
